Loading company…
TrueSimple Bio develops drug candidates for oncology and autoimmune diseases.
TrueSimple Bio conducts research and development on drugs for oncology and autoimmune diseases. Founded in 2025, the company is based in Hangzhou, China. In March 2026, it raised venture funding from Fontus Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in